IndraLab

Statements

STAMBPL1 activates Cholangiocarcinoma. 1 / 1

| 1

reach

"This study firstly reveals that STAMBPL1 promotes cholangiocarcinoma progression by upregulating NRF2, indicating that targeting the STAMBPL1/NRF2 axis is a novel therapeutic strategy."

39706065

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

STAMBPL1 activates Cholangiocarcinoma. 1 / 1

INDRA sources:

Databases

Reading